In Response to Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option

Zhaosheng Jin; Tong J. Gan; Kumar G. Belani; Sergio Bergese; Frances Chung; Pierre Diemunsch; Ashraf S. Habib; Anthony L. Kovac; Tricia A. Meyer; Richard D. Urman; Christian C. Apfel; Sabry Ayad; Linda Beagley; Keith Candiotti; Marina Englesakis; Traci L. Hedrick; Peter Kranke; Samuel Lee; Daniel Lipman; Harold S. Minkowitz; John Morton; Beverly K. Philip

doi:10.1213/ane.0000000000005280

In Response to Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option

Zhaosheng Jin
, Tong J. Gan
, Kumar G. Belani
, Sergio Bergese
, Frances Chung
, Pierre Diemunsch
, Ashraf S. Habib
, Anthony L. Kovac
, Tricia A. Meyer
, Richard D. Urman
, Christian C. Apfel
, Sabry Ayad
, Linda Beagley
, Keith Candiotti
, Marina Englesakis
, Traci L. Hedrick
, Peter Kranke
, Samuel Lee
, Daniel Lipman
, Harold S. Minkowitz

John Morton, Beverly K. Philip

Anesthesiology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	E31-E33
Journal	Anesthesia and analgesia
Volume	132
Issue number	2
DOIs	https://doi.org/10.1213/ane.0000000000005280
State	Published - Feb 1 2021

Bibliographical note

Funding Information:
Conflicts of Interest: The faculty received reimbursement for travel expenses attending the meeting. No honorarium was provided. T. J. Gan: Honoraria from Acacia, Edwards, Masimo, Medtronic, Merck and Mallinckrodt. S. Bergese: Acacia (Funding for Clinical Trial to Ohio State University). F. Chung has received research support from the Ontario Ministry of Health and Long-Term Care, University Health Network Foundation, Acacia Pharma, Medtronics grants to institution outside of the submitted work, Up-to-date royalties, STOP-Bang proprietary to University Health Network. Speaker honorarium from Baxter Pharma. P. Diemunsch: Ambu: Member of an advisors panel on airway management, Fisher & Paykel: Research Grants, paid conferences, French Government: Expert at the Court of Appeal, Acacia Pharma: Research Grants, MSD: Member of an advisory panel on ERAS. A. S. Habib: Funded Research: Pacira Biosciences, Avanos Medical Inc., Advisory Board: Takeda. A. L. Kovac: Merck (speaker’s bureau), Helsinn (speaker’s bureau), Mundipharma (speaker’s bureau), Acacia (speaker’s bureau). T. A. Meyer: Acacia, Neumentum. R. D. Urman: Merck (research funding); Medtronic (consulting fees and research funding); Takeda (consulting fees); Acacia (consulting fees and research funding); Posimir (consulting fees). S. Ayad: Pacira, Medtronic and Acacia. K. Candiotti: Research support-Acacia, Pfizer, Takeda; Consulting-Acacia, Pfizer, Takeda. T. L. Hedrick: MedEdicus. P. Kranke acted as investigator in phase III trials on amisulpride during the last 3 years. He gave invited lectures for FreseniusKabi (propofol), Grünenthal, CSL-Behring, TevaRatiopharm. H. S. Minkowitz: Acacia, AcelRX, Adynxx, Concentric, Durect, Heron, Merck, Mallinckrodt, Innocoll, Pacira, Neumentum, Westward, Trevena, Takeda. J. Morton: Medtronic, Olympus, Novo Nordisk.

Keywords

Humans
Postoperative Nausea and Vomiting

PubMed: MeSH publication types

Comment
Journal Article

Publisher link

10.1213/ane.0000000000005280

Find It

Find It at U of M Libraries

Cite this

Jin, Z., Gan, T. J., Belani, K. G., Bergese, S., Chung, F., Diemunsch, P., Habib, A. S., Kovac, A. L., Meyer, T. A., Urman, R. D., Apfel, C. C., Ayad, S., Beagley, L., Candiotti, K., Englesakis, M., Hedrick, T. L., Kranke, P., Lee, S., Lipman, D., ... Philip, B. K. (2021). In Response to Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option. Anesthesia and analgesia, 132(2), E31-E33. https://doi.org/10.1213/ane.0000000000005280

Jin, Z, Gan, TJ, Belani, KG, Bergese, S, Chung, F, Diemunsch, P, Habib, AS, Kovac, AL, Meyer, TA, Urman, RD, Apfel, CC, Ayad, S, Beagley, L, Candiotti, K, Englesakis, M, Hedrick, TL, Kranke, P, Lee, S, Lipman, D, Minkowitz, HS, Morton, J & Philip, BK 2021, 'In Response to Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option', Anesthesia and analgesia, vol. 132, no. 2, pp. E31-E33. https://doi.org/10.1213/ane.0000000000005280

@article{8af57fe8867f456fac426fcbd8376cd1,

title = "In Response to Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option",

keywords = "Humans, Postoperative Nausea and Vomiting",

author = "Zhaosheng Jin and Gan, \{Tong J.\} and Belani, \{Kumar G.\} and Sergio Bergese and Frances Chung and Pierre Diemunsch and Habib, \{Ashraf S.\} and Kovac, \{Anthony L.\} and Meyer, \{Tricia A.\} and Urman, \{Richard D.\} and Apfel, \{Christian C.\} and Sabry Ayad and Linda Beagley and Keith Candiotti and Marina Englesakis and Hedrick, \{Traci L.\} and Peter Kranke and Samuel Lee and Daniel Lipman and Minkowitz, \{Harold S.\} and John Morton and Philip, \{Beverly K.\}",

note = "Funding Information: Conflicts of Interest: The faculty received reimbursement for travel expenses attending the meeting. No honorarium was provided. T. J. Gan: Honoraria from Acacia, Edwards, Masimo, Medtronic, Merck and Mallinckrodt. S. Bergese: Acacia (Funding for Clinical Trial to Ohio State University). F. Chung has received research support from the Ontario Ministry of Health and Long-Term Care, University Health Network Foundation, Acacia Pharma, Medtronics grants to institution outside of the submitted work, Up-to-date royalties, STOP-Bang proprietary to University Health Network. Speaker honorarium from Baxter Pharma. P. Diemunsch: Ambu: Member of an advisors panel on airway management, Fisher \& Paykel: Research Grants, paid conferences, French Government: Expert at the Court of Appeal, Acacia Pharma: Research Grants, MSD: Member of an advisory panel on ERAS. A. S. Habib: Funded Research: Pacira Biosciences, Avanos Medical Inc., Advisory Board: Takeda. A. L. Kovac: Merck (speaker{\textquoteright}s bureau), Helsinn (speaker{\textquoteright}s bureau), Mundipharma (speaker{\textquoteright}s bureau), Acacia (speaker{\textquoteright}s bureau). T. A. Meyer: Acacia, Neumentum. R. D. Urman: Merck (research funding); Medtronic (consulting fees and research funding); Takeda (consulting fees); Acacia (consulting fees and research funding); Posimir (consulting fees). S. Ayad: Pacira, Medtronic and Acacia. K. Candiotti: Research support-Acacia, Pfizer, Takeda; Consulting-Acacia, Pfizer, Takeda. T. L. Hedrick: MedEdicus. P. Kranke acted as investigator in phase III trials on amisulpride during the last 3 years. He gave invited lectures for FreseniusKabi (propofol), Gr{\"u}nenthal, CSL-Behring, TevaRatiopharm. H. S. Minkowitz: Acacia, AcelRX, Adynxx, Concentric, Durect, Heron, Merck, Mallinckrodt, Innocoll, Pacira, Neumentum, Westward, Trevena, Takeda. J. Morton: Medtronic, Olympus, Novo Nordisk.",

year = "2021",

month = feb,

day = "1",

doi = "10.1213/ane.0000000000005280",

language = "English (US)",

volume = "132",

pages = "E31--E33",

journal = "Anesthesia and analgesia",

issn = "0003-2999",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - In Response to Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option

AU - Jin, Zhaosheng

AU - Gan, Tong J.

AU - Belani, Kumar G.

AU - Bergese, Sergio

AU - Chung, Frances

AU - Diemunsch, Pierre

AU - Habib, Ashraf S.

AU - Kovac, Anthony L.

AU - Meyer, Tricia A.

AU - Urman, Richard D.

AU - Apfel, Christian C.

AU - Ayad, Sabry

AU - Beagley, Linda

AU - Candiotti, Keith

AU - Englesakis, Marina

AU - Hedrick, Traci L.

AU - Kranke, Peter

AU - Lee, Samuel

AU - Lipman, Daniel

AU - Minkowitz, Harold S.

AU - Morton, John

AU - Philip, Beverly K.

N1 - Funding Information: Conflicts of Interest: The faculty received reimbursement for travel expenses attending the meeting. No honorarium was provided. T. J. Gan: Honoraria from Acacia, Edwards, Masimo, Medtronic, Merck and Mallinckrodt. S. Bergese: Acacia (Funding for Clinical Trial to Ohio State University). F. Chung has received research support from the Ontario Ministry of Health and Long-Term Care, University Health Network Foundation, Acacia Pharma, Medtronics grants to institution outside of the submitted work, Up-to-date royalties, STOP-Bang proprietary to University Health Network. Speaker honorarium from Baxter Pharma. P. Diemunsch: Ambu: Member of an advisors panel on airway management, Fisher & Paykel: Research Grants, paid conferences, French Government: Expert at the Court of Appeal, Acacia Pharma: Research Grants, MSD: Member of an advisory panel on ERAS. A. S. Habib: Funded Research: Pacira Biosciences, Avanos Medical Inc., Advisory Board: Takeda. A. L. Kovac: Merck (speaker’s bureau), Helsinn (speaker’s bureau), Mundipharma (speaker’s bureau), Acacia (speaker’s bureau). T. A. Meyer: Acacia, Neumentum. R. D. Urman: Merck (research funding); Medtronic (consulting fees and research funding); Takeda (consulting fees); Acacia (consulting fees and research funding); Posimir (consulting fees). S. Ayad: Pacira, Medtronic and Acacia. K. Candiotti: Research support-Acacia, Pfizer, Takeda; Consulting-Acacia, Pfizer, Takeda. T. L. Hedrick: MedEdicus. P. Kranke acted as investigator in phase III trials on amisulpride during the last 3 years. He gave invited lectures for FreseniusKabi (propofol), Grünenthal, CSL-Behring, TevaRatiopharm. H. S. Minkowitz: Acacia, AcelRX, Adynxx, Concentric, Durect, Heron, Merck, Mallinckrodt, Innocoll, Pacira, Neumentum, Westward, Trevena, Takeda. J. Morton: Medtronic, Olympus, Novo Nordisk.

PY - 2021/2/1

Y1 - 2021/2/1

KW - Humans

KW - Postoperative Nausea and Vomiting

UR - https://www.scopus.com/pages/publications/85100125883

UR - https://www.scopus.com/pages/publications/85100125883#tab=citedBy

U2 - 10.1213/ane.0000000000005280

DO - 10.1213/ane.0000000000005280

M3 - Letter

C2 - 33449569

AN - SCOPUS:85100125883

SN - 0003-2999

VL - 132

SP - E31-E33

JO - Anesthesia and analgesia

JF - Anesthesia and analgesia

IS - 2

ER -

In Response to Oral Perphenazine 8 mg: A Low-Cost, Efficacious Antiemetic Option

Bibliographical note

Keywords

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Cite this